Emerging Infectious Diseases Journal: A Time of Transition by McDade, Joseph E. & Hughes, James M.
EDITORIAL
Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002 103
hange is a constant for Emerging
Infectious Diseases. Since its incep-
tion in 1995, the journal has undergone
many transformations: its content has
broadened, its format has become more
distinctive, and its frequency of publica-
tion has increased, from quarterly to
bimonthly in 1999 and now to monthly
with this issue. Yet, amidst all the
changes, Emerging Infectious Diseases
has found its niche in the ranks of scien-
tific journals, serving the needs of pro-
fessionals in infectious diseases and
many related disciplines. In 7 short
years, the journal has achieved a high
impact factor (#3 of 36 infectious dis-
ease journals, ISI Citation Reports,
2000); indexing in Medline, Current
Contents, and other major databases;
translations into Spanish, Japanese, Chi-
nese, and French; and a circulation of
more than 45,000 subscribers to its print
and electronic versions. The journal has
also provided a new communication
channel through which to encourage glo-
bal investigation and dialogue on the
many issues, challenges, and opportuni-
ties posed by emerging infectious dis-
eases.
The goals of the journal stem directly
from the Centers for Disease Control and
Prevention’s (CDC’s) action plan against
emerging infections: recognition of new
and reemerging infections; understand-
ing of factors involved in disease emer-
gence, prevention, and elimination; and
fast and broad dissemination of reliable
information on emerging infections
around the world. Toward these goals,
the journal 1) provides information on
factors known to influence emergence:
microbial adaptation and change, human
demographics and behavior, technology
and industry, economic development and
land use, international travel and com-
merce, and the breakdown of public
health measures; 2) reports laboratory
and epidemiologic findings within a
broader public health perspective; 3)
provides timely updates of infectious
disease trends and research (new meth-
ods of detecting, characterizing, or sub-
typing pathogens; developments in
antimicrobial drugs, vaccines, and pre-
vention or elimination programs; case
reports); 4) publishes reports of interest
to researchers in infectious diseases and
related sciences, as well as to public
health generalists learning the scientific
basis for prevention programs; 5)
encourages insightful analysis and com-
mentary, stimulating global interest in
and discussion of emerging infectious
disease issues; and 6) harnesses elec-
tronic technology to expedite and
enhance global dissemination of emerg-
ing infectious disease information.  
In pursuing these goals, the journal
has set a high standard of quality, not
only for its peer-reviewed scientific con-
tent but also for the readability and
accessibility of this content. A modern
journal functions in a fast-paced world
of information overload, instant access,
overburdened scientific audience, and
the accidental broader audience created
by the World-Wide Web. To fulfill the
increasing expectations of an expanding
audience that includes scientists in many
disciplines, public health generalists,
students, and the public, articles are
edited for language, communication
effectiveness, style, and length. The
human aspect of scientific research is
always kept in the forefront by the asso-
ciation of scientific research with works
of art on the journal’s cover and by
“Another Dimension” articles,  remind-
ing the reader that, in the end, the pur-
pose of all scientific endeavor is the
betterment of humanity and the improve-
ment of the quality of life for all people. 
The journal relies on a broad interna-
tional authorship base and rigorous inde-
pendent peer review to provide accurate
and reliable scientific information on
emerging infections, free of charge,
around the globe.  The journal draws
authors and readers from professionals
in infectious diseases and many other
scientific disciplines in the United States
and abroad,  specialists in academia,
industry, clinical practice, and public
health, as well as economics, demogra-
phy, and sociology.  To expedite dissemi-
nation of up-to-the-minute information,
from its inception Emerging Infectious
Diseases has published articles online
ahead of print.    
Since 1995, Emerging Infectious
Diseases has published new scientific
research, analysis and commentary, pol-
icy reviews, and concise synopses on a
broad array of infectious disease topics.
Coverage has included topics as diverse
as Morbillivirus in Australia, tuberculo-
sis trends in Japan, antimicrobial resis-
tance in Europe, infectious disease
emergence in New Zealand, genomics
and bacterial pathogenesis, amphibian
population declines, the role of migra-
tory birds in the spread of  West Nile
virus, infections in the health-care set-
ting, bovine spongiform encephalopathy
and variant Creutzfeldt-Jakob disease,
and bioterrorism.
In 2002, the journal remains at the
crossroads of change. Upon my retire-
ment from CDC, D. Peter Drotman, a
senior scientist with the National Center
for Infectious Diseases, became Interim
Editor while a search is conducted for a
new Editor-in-Chief. To the role of
Interim Editor, Dr. Drotman brings a
broad knowledge of infectious diseases,
effective leadership, and boundless
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enthusiasm. A veteran of the successful
World Health Organization Smallpox
Eradication Programme, he was among
the first CDC scientists assigned to
investigate cases of what was later to be
named AIDS.
 In the meantime, infections continue
to emerge: new infections resulting from
changes or evolution of existing organ-
isms, known infections spreading to new
geographic areas or populations, previ-
ously unrecognized infections appearing
in areas undergoing ecologic transforma-
tion, old infections reemerging as a
result of antimicrobial resistance in
known agents or breakdowns in public
health measures. The recent appearance
of West Nile virus in the United States
and the use of  Bacillus anthracis in
recent bioterrorism attacks are reminders
of the need for vigilance and the undi-
minished potential for global dissemina-
tion of infectious agents.
As a monthly journal in 2002,
Emerging Infectious Diseases will con-
tinue to track and analyze infectious dis-
ease trends and to encourage
investigation and timely communication
of emerging threats and critical related
issues around the world. Advances in
electronic publishing allow unprece-
dented speed in disseminating public
health information and create new
opportunities for innovation and
improvements in communication. Elec-
tronic submission and peer review of
manuscripts, online publication ahead of
print, online-only publication, and con-
venient links to other sources of biomed-
ical information are only the beginning.
Dr. McDade is Founding Editor, Emerging
Infectious Diseases Journal. Dr. Hughes is
Director, National Center for Infectious Dis-
eases, Centers for Disease Control and Pre-
vention, Atlanta, Georgia, USA
OPPORTUNITIES FOR
PEER REVIEWERS
The editors of Emerging Infectious Diseases seek
to increase the roster of reviewers for manuscripts
submitted by authors all over the world for publication
in the journal. If you are interested in reviewing arti-
cles on emerging infectious disease topics, please e-
mail your name, address, qualifications or curriculum
vitae, and areas of expertise to eideditor@cdc.gov 
At Emerging Infectious Diseases, we always
request reviewers’ consent before sending manu-
scripts, limit review requests to three or four per year,
and allow 2-4 weeks for completion of reviews. We
consider reviewers invaluable in the process of select-
ing and publishing high-quality scientific articles and
acknowledge their contributions in the journal once a
year. 
Even though it brings no financial compensation,
participation in the peer-review process is not without
rewards. Manuscript review provides scientists at all
stages of their career opportunities for professional
growth by familiarizing them with research trends and
the latest work in the field of infectious diseases and
by improving their own skills for presenting scientific
information through constructive criticism of those of
their peers. To view the spectrum of articles we pub-
lish, information for authors, and our extensive style
guide, visit the journal web site at www.cdc.gov/eid .
For more information on participating in the peer-
review process of Emerging Infectious Diseases, e-
mail eideditor@cdc.gov or call the journal office at
404-371-5329.
International Conference on
Emerging Infectious Diseases, 2002
The National Center for Infectious Diseases,
Centers for Disease Control and Prevention, has
scheduled the Third International Conference on
Emerging Infectious Diseases for March 24-27, 2002,
at the Hyatt Regency Hotel, Atlanta, Georgia, USA.
More than 2,500 participants are expected, represent-
ing many nations and disciplines. They will discuss
the latest information on many aspects of new and
reemerging pathogens, such as West Nile virus and
issues concerning bioterrorism.
Conference information is available
at http://www.cdc.gov/iceid
 The Call for Abstracts is available
at http://www.asmusa.org/mtgscr/iceido2.htm
Contact person is Charles Schable, cas1@cdc.gov